Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Thompson

Showing results (401-410 of 412) with videos related to

Pageof 42
Sort By:
Transplantation Proceedings|May 30, 2002
Serum citrulline as a marker of acute cellular rejection for intestinal transplantationP A Pappas, J-M Saudubray, A G Tzakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2020
Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumorM-A El Sharouni, M D Stodell, T Ahmed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patientsJ H Lee, R P Saw, J F Thompson, et al.
Annals of Surgical Oncology|September 14, 2019
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of LifeMichael A Henderson, D Gyorki, B H Burmeister, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
The British Journal of Dermatology|September 15, 2019
A risk prediction model for the development of subsequent primary melanoma in a population-based cohortA E Cust, C Badcock, J Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.
The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemC M Balch, S J Soong, J E Gershenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, S J Soong, et al.
Pageof 42

Showing results (401-410 of 412) with videos related to

Sort By:
Pageof 42
Transplantation Proceedings|May 30, 2002
Serum citrulline as a marker of acute cellular rejection for intestinal transplantationP A Pappas, J-M Saudubray, A G Tzakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2020
Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumorM-A El Sharouni, M D Stodell, T Ahmed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patientsJ H Lee, R P Saw, J F Thompson, et al.
Annals of Surgical Oncology|September 14, 2019
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of LifeMichael A Henderson, D Gyorki, B H Burmeister, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
The British Journal of Dermatology|September 15, 2019
A risk prediction model for the development of subsequent primary melanoma in a population-based cohortA E Cust, C Badcock, J Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.
The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemC M Balch, S J Soong, J E Gershenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, S J Soong, et al.
Pageof 42